Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Terminated 5Withdrawn 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 14Solid Tumor 12Mesothelioma 12Unspecified Adult Solid Tumor, Protocol Specific 9Solid Tumors 9Advanced Solid Tumors 8Carcinoma, Non-Small-Cell Lung 7Small Cell Lung Carcinoma 6Retinoblastoma 5Advanced Solid Tumor 5Solid Tumor, Adult 4Lung Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Neoplasms 2Metastatic Solid Tumors 2Melanoma 2Carcinoma, Renal Cell 2Carcinoma 2Anus Neoplasms 2Xerophthalmia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor 1Triple Negative Breast Neoplasms 1Trachoma 1

Interventions

rilotumumab 1Pemetrexed 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Solitary Fibrous Tumor, Pleural × Other solid neoplasm × Clear all
NCT01105390 2013-08-02

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 2 Withdrawn
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡